| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | TABLET, DELAYED RELEASE / ORAL | | 4 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, EMULSION / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 5.4 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAMUSCULAR | | 101 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / RECTAL | NA | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | | 265 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRADERMAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRACARDIAC | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER, FOR SUSPENSION / ORAL | | 9 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 7.01 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRAPERITONEAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRATHECAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRA-ARTICULAR | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | LIQUID / TOPICAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRAVITREAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / URETERAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / PARENTERAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / AURICULAR (OTIC) | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | | 12 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRASYNOVIAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| NONOXYNOL-9 | NONOXYNOL-9 | 48Q180SH9T | SOLUTION / OPHTHALMIC | 0.13 %w/w | | Exact identifier — unii candidate 2 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-AMNIOTIC | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / NASAL | 20 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-ARTERIAL | 176 mg | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / TOPICAL | 4.35 %w/v | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / SOFT TISSUE | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION/ DROPS / AURICULAR (OTIC) | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE / ORAL | | 131 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INTRA-ARTERIAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | GEL / VAGINAL | | 20 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | POWDER / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SPONGE / TOPICAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTABLE, LIPOSOMAL / INTRAVENOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | | 1971 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | GEL / TOPICAL | | 3 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / ORAL | | 9120 mg | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / ORAL | | 15 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / INTRASYNOVIAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SUBCONJUNCTIVAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / SUBCUTANEOUS | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | EMULSION / TOPICAL | 0.2 %w/w | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | | 2000 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAOCULAR | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | AEROSOL / TOPICAL | 0.08 %w/w | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRABURSAL | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EFFERVESCENT / ORAL | | 840 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | | Exact identifier — unii candidate 75 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CREAM / TOPICAL | | 1 mg | Exact identifier — unii candidate 61 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / OPHTHALMIC | 0.09 %w/v | | Exact identifier — unii candidate 61 equally ranked IID candidates |
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | | 12 mg | Exact identifier — unii candidate 75 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / SOFT TISSUE | ADJ PH | | Exact identifier — unii candidate 174 equally ranked IID candidates |